Month: July 2020

SAN DIEGO and TORONTO, July 15, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it priced its previously announced underwritten public offering of 10,500,000 common shares (the “Offering”) at a public offering price of US$5.25 per share. Gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by Aptose, are expected to be approximately US$55 million. The underwriters have been granted a 30-day option to purchase up to an additional 1,575,000 common shares in the Offering, under the same terms and conditions. The Offering is expected to close on or about July 20, 2020, subject to satisfaction of customary closing conditions.Aptose intends to use the net proceeds of the Offering to (i) accelerate...

TORONTO, July 15, 2020 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (the “Company” or “Platinex“) is pleased to announce that it has completed its previously announced non-brokered private placement (the “Private Placement“), issuing a total of 11,843,333 units (“Units“) for gross proceeds of $355,300. The size of the offering was increased due to market demand. Each Unit consists of one common share (a “Common Share“) of the Company and one common share purchase warrant (a “Warrant“) of the Company. Each Warrant entitles the holder to acquire one additional Common Share at an exercise price of $0.075 for a period of 24 months from the date of issuance.The Company intends to use the proceeds of the Private Placement to incur exploration expenses on its Shining...

VANCOUVER, July 15, 2020 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has terminated certain related party agreements pertaining to consulting services and a loan facility.Emerald Health Sciences Inc. (“EHS”), a control person of Emerald, and Emerald entered into an independent contractor agreement on May 1, 2015, as amended from time to time (the “Consulting Agreement”), and a loan agreement on August 25, 2015, as amended from time to time (the “Loan Agreement”). EHS and Emerald have agreed to terminate the Consulting Agreement and Loan Agreement effective immediately.In addition, Emerald’s 51%-owned joint venture, Emerald Health Naturals Inc., and Avricore Health Inc. (then named VANC Pharmaceuticals, Inc.) have terminated a supply and distribution agreement that was entered...

CE COMMUNIQUÉ NE DOIT PAS ÊTRE ENVOYÉ AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSÉ AUX ÉTATS-UNIS.MONTRÉAL, 15 juill. 2020 (GLOBE NEWSWIRE) — Marché Goodfood Corp. (« Marché Goodfood » ou la « Société ») (TSX : FOOD), un chef de file dans l’épicerie en ligne au Canada, a annoncé aujourd’hui avoir conclu une entente avec un syndicat de preneurs fermes mené conjointement par Desjardins Marchés des capitaux et Stifel GMP (ensemble, les « preneurs fermes co-chefs de file » et, collectivement avec le syndicat de preneurs fermes, les « preneurs fermes »), aux termes de laquelle les preneurs fermes ont convenu d’acheter, auprès de la Société, 4 135 000 actions ordinaires de la Société (les « actions nouvellement émises »), et auprès de MM. Jonathan Ferrari, président du conseil et chef de la direction de la Société, Neil Cuggy, président...

Not For Distribution To United States Newswire Services Or For Dissemination In The United StatesTORONTO, July 15, 2020 (GLOBE NEWSWIRE) — Bunker Hill Mining Corporation (the “Company”) (CSE:BNKR) is pleased to announce a first progress update following the change in management which occurred earlier this year.Management’s focus is to explore the high-grade silver potential of the Bunker Hill mine, which was previously operated as a lead metal mine for 95 years ending in 1981. A total of 162 million ounces of silver were produced as a byproduct over this period.The following historical drill intercepts have been identified in historic data. These are examples of the data that is being used to inform the next phase of silver focused exploration.It is noted that these drill results were not compiled under the supervision of a Qualified...

WAYZATA, Minn., July 15, 2020 (GLOBE NEWSWIRE) — Trean Insurance Group, Inc. (“Trean”) today announced the pricing of its initial public offering of 10,714,286 shares of common stock at a price of $15.00 per share.  The shares are expected to begin trading on the Nasdaq Global Select Market on July 16, 2020 under the symbol “TIG.”  The offering is expected to close on July 20, 2020, subject to customary closing conditions.Trean is offering 7,142,857 shares of common stock and the selling stockholders named in the prospectus are offering 3,571,429 shares of common stock.  The underwriters have a 30-day option to purchase up to an additional 1,607,142 shares of common stock from certain of the selling stockholders.  Trean will not receive any proceeds from the sale of shares by the selling stockholders.J.P. Morgan, Evercore ISI and...

TORONTO, July 15, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the pricing of an underwritten public offering (the “Offering”) of 2,758,621 common shares of the Company (the “Common Shares”), at a price of US$14.50 per Common Share (the “Offering Price”).The aggregate gross proceeds to the Company are expected to be US$40,000,005. The Company has also granted the underwriters an over-allotment option to purchase up to an additional 413,793 Common Shares at the Offering Price, exercisable in whole or in part at any time up to 30 days from the closing.Jefferies, Cowen and Raymond James are acting as joint book-running managers for the Offering.The Offering is being made pursuant to a prospectus supplement (the “Prospectus Supplement”) to the Company’s short...

CAMBRIDGE, Mass., July 15, 2020 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, today announced the pricing of its initial public offering of 20,000,000 shares of its common stock at a price to the public of $20.00 per share. All of the shares are being offered by Relay Therapeutics. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Relay Therapeutics, are expected to be $400.0 million. In addition, the underwriters have a 30-day option to purchase up to 3,000,000 additional shares of common stock at the initial public offering price less underwriting discounts and commissions. The shares are expected...

VANCOUVER, British Columbia, July 15, 2020 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI) announces that further to its news release of May 27, 2020, the Company has filed its quarterly financial statements and accompanying management’s discussion and analysis, and related CEO and CFO certifications for the three months ended March 31, 2020 (collectively, the “Quarterly Filings”). Readers should refer to the July 15, 2020 Management’s Discussion and Analysis, and the consolidated interim financial statements for complete information, which are available on SEDAR at www.sedar.com.The Company continues to focus on its cryptocurrency mining operations and on improving its gross profit by focusing on improving the efficiency of its digital currency mining. The Company is evaluating its options to...

ALMONTE, Ontario, July 15, 2020 (GLOBE NEWSWIRE) — 3 Sixty Risk Solutions Ltd. (“3 Sixty” or the “Company”) (CSE: SAFE) (OTCQB: SAYFF) (FSE: 62P2) announced today that the release of its financial results for the fourth quarter and fiscal year ended December 31, 2019 will be further delayed. Though the Company was nearing completion of the necessary procedures to finalize the audit of the year-end financial statements in order to effect the necessary filings on July 15, 2020 as previously indicated, the Company was made aware of the need to reassess the amounts recorded in the Company’s interim financial statements for intangible assets and goodwill for each of the three month periods ended March 31, 2019, June 30, 2019 and September 30, 2019 (collectively, the “2019 Interim Results”) as it relates to the Company’s acquisition of...